title: Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients.
abstract: OBJECTIVE
  To evaluate adherence to antihypertensive therapy (AHT) and the association between adherence to AHT, all-cause mortality, and cardiovascular (CV) morbidity in a large cohort of patients newly treated with antihypertensives in a clinical practice setting.
  
  
  METHODS
  An administrative database kept by the Local Health Unit of Florence (Italy) listing patient baseline characteristics, drug prescription, and hospital admission information was used to perform a population-based retrospective study including patients newly treated with antihypertensives, ≥18 years of age, with a first prescription between January 1, 2004 and December 31, 2006. Patients using antihypertensives for secondary prevention of CV disease, occasional spot users, and patients with early CV events, were excluded from the study cohort. Adherence to AHT was calculated and classified as poor, moderate, good, and excellent. A Cox regression model was conducted to determine the association among adherence to AHT and risk of all-cause mortality, stroke, or acute myocardial infarction.
  
  
  RESULTS
  A total of 31,306 patients, 15,031 men (48.0%), and 16,275 women (52.0%), with a mean age of 60.2 ± 14.5 years was included in the study. Adherence to AHT was poor in 8038 patients (25.7% of included patients), moderate in 4640 (14.8%), good in 5651 (18.1%), and excellent in 12,977 (41.5%). Compared with patients with poor adherence (hazard ratio [HR] = 1), the risk of all-cause death, stroke, or acute myocardial infarction was significantly lower in patients with good (HR = 0.69, P < 0.001) and excellent adherence (HR = 0.53, P < 0.001).
  
  
  CONCLUSIONS
  These findings indicate that suboptimal adherence to AHT occurs in a substantial proportion of patients and is associated with poor health outcomes already in primary prevention of CV diseases. For health authorities, this preliminary evidence underlines the need for monitoring and improving medication adherence in clinical practice.
authors.affiliation: CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna, Italy;
authors.forename: Luca
authors.initials: L
authors.lastname: Degli Esposti
authors.forename: Stefania
authors.initials: S
authors.lastname: Saragoni
authors.forename: Silvia
authors.initials: S
authors.lastname: Benemei
authors.forename: Paolo
authors.initials: P
authors.lastname: Batacchi
authors.forename: Pierangelo
authors.initials: P
authors.lastname: Geppetti
authors.forename: Mauro
authors.initials: M
authors.lastname: Di Bari
authors.forename: Niccolò
authors.initials: N
authors.lastname: Marchionni
authors.forename: Alessandra
authors.initials: A
authors.lastname: Sturani
authors.forename: Stefano
authors.initials: S
authors.lastname: Buda
authors.forename: Ezio
authors.initials: E
authors.lastname: Degli Esposti